The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Molecular Diagnostic Systems Market Research Report 2025
Synopsis
Molecular Diagnostic Systems
The global Molecular Diagnostic Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostic Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostic Systems.
Report Scope
The Molecular Diagnostic Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Diagnostic Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Diagnostic Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siemens
Roche
Cepheid
BD
Adaltis Srl
NeuMoDx
Abbott
Hologic
Mobidiag
microLIQUID
Bruker
Mesa Biotech
Segment by Type
Stationary
Handheld
Segment by Application
Infectious Disease
Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Molecular Diagnostic Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Molecular Diagnostic Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Molecular Diagnostic Systems
The global Molecular Diagnostic Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostic Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostic Systems.
Report Scope
The Molecular Diagnostic Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Diagnostic Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Diagnostic Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siemens
Roche
Cepheid
BD
Adaltis Srl
NeuMoDx
Abbott
Hologic
Mobidiag
microLIQUID
Bruker
Mesa Biotech
Segment by Type
Stationary
Handheld
Segment by Application
Infectious Disease
Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Molecular Diagnostic Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Molecular Diagnostic Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Molecular Diagnostic Systems Market Overview
1.1 Product Overview and Scope of Molecular Diagnostic Systems
1.2 Molecular Diagnostic Systems Segment by Type
1.2.1 Global Molecular Diagnostic Systems Market Value Comparison by Type (2024-2030)
1.2.2 Stationary
1.2.3 Handheld
1.3 Molecular Diagnostic Systems Segment by Application
1.3.1 Global Molecular Diagnostic Systems Market Value by Application: (2024-2030)
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Others
1.4 Global Molecular Diagnostic Systems Market Size Estimates and Forecasts
1.4.1 Global Molecular Diagnostic Systems Revenue 2019-2030
1.4.2 Global Molecular Diagnostic Systems Sales 2019-2030
1.4.3 Global Molecular Diagnostic Systems Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Molecular Diagnostic Systems Market Competition by Manufacturers
2.1 Global Molecular Diagnostic Systems Sales Market Share by Manufacturers (2019-2024)
2.2 Global Molecular Diagnostic Systems Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Molecular Diagnostic Systems Average Price by Manufacturers (2019-2024)
2.4 Global Molecular Diagnostic Systems Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Molecular Diagnostic Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Molecular Diagnostic Systems, Product Type & Application
2.7 Molecular Diagnostic Systems Market Competitive Situation and Trends
2.7.1 Molecular Diagnostic Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Molecular Diagnostic Systems Players Market Share by Revenue
2.7.3 Global Molecular Diagnostic Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Molecular Diagnostic Systems Retrospective Market Scenario by Region
3.1 Global Molecular Diagnostic Systems Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Molecular Diagnostic Systems Global Molecular Diagnostic Systems Sales by Region: 2019-2030
3.2.1 Global Molecular Diagnostic Systems Sales by Region: 2019-2024
3.2.2 Global Molecular Diagnostic Systems Sales by Region: 2025-2030
3.3 Global Molecular Diagnostic Systems Global Molecular Diagnostic Systems Revenue by Region: 2019-2030
3.3.1 Global Molecular Diagnostic Systems Revenue by Region: 2019-2024
3.3.2 Global Molecular Diagnostic Systems Revenue by Region: 2025-2030
3.4 North America Molecular Diagnostic Systems Market Facts & Figures by Country
3.4.1 North America Molecular Diagnostic Systems Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Molecular Diagnostic Systems Sales by Country (2019-2030)
3.4.3 North America Molecular Diagnostic Systems Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Molecular Diagnostic Systems Market Facts & Figures by Country
3.5.1 Europe Molecular Diagnostic Systems Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Molecular Diagnostic Systems Sales by Country (2019-2030)
3.5.3 Europe Molecular Diagnostic Systems Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Molecular Diagnostic Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Molecular Diagnostic Systems Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Molecular Diagnostic Systems Sales by Country (2019-2030)
3.6.3 Asia Pacific Molecular Diagnostic Systems Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Molecular Diagnostic Systems Market Facts & Figures by Country
3.7.1 Latin America Molecular Diagnostic Systems Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Molecular Diagnostic Systems Sales by Country (2019-2030)
3.7.3 Latin America Molecular Diagnostic Systems Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Molecular Diagnostic Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Molecular Diagnostic Systems Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Molecular Diagnostic Systems Sales by Country (2019-2030)
3.8.3 Middle East and Africa Molecular Diagnostic Systems Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Molecular Diagnostic Systems Sales by Type (2019-2030)
4.1.1 Global Molecular Diagnostic Systems Sales by Type (2019-2024)
4.1.2 Global Molecular Diagnostic Systems Sales by Type (2025-2030)
4.1.3 Global Molecular Diagnostic Systems Sales Market Share by Type (2019-2030)
4.2 Global Molecular Diagnostic Systems Revenue by Type (2019-2030)
4.2.1 Global Molecular Diagnostic Systems Revenue by Type (2019-2024)
4.2.2 Global Molecular Diagnostic Systems Revenue by Type (2025-2030)
4.2.3 Global Molecular Diagnostic Systems Revenue Market Share by Type (2019-2030)
4.3 Global Molecular Diagnostic Systems Price by Type (2019-2030)
5 Segment by Application
5.1 Global Molecular Diagnostic Systems Sales by Application (2019-2030)
5.1.1 Global Molecular Diagnostic Systems Sales by Application (2019-2024)
5.1.2 Global Molecular Diagnostic Systems Sales by Application (2025-2030)
5.1.3 Global Molecular Diagnostic Systems Sales Market Share by Application (2019-2030)
5.2 Global Molecular Diagnostic Systems Revenue by Application (2019-2030)
5.2.1 Global Molecular Diagnostic Systems Revenue by Application (2019-2024)
5.2.2 Global Molecular Diagnostic Systems Revenue by Application (2025-2030)
5.2.3 Global Molecular Diagnostic Systems Revenue Market Share by Application (2019-2030)
5.3 Global Molecular Diagnostic Systems Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Siemens
6.1.1 Siemens Corporation Information
6.1.2 Siemens Description and Business Overview
6.1.3 Siemens Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Siemens Molecular Diagnostic Systems Product Portfolio
6.1.5 Siemens Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Roche Molecular Diagnostic Systems Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Cepheid
6.3.1 Cepheid Corporation Information
6.3.2 Cepheid Description and Business Overview
6.3.3 Cepheid Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cepheid Molecular Diagnostic Systems Product Portfolio
6.3.5 Cepheid Recent Developments/Updates
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Description and Business Overview
6.4.3 BD Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BD Molecular Diagnostic Systems Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Adaltis Srl
6.5.1 Adaltis Srl Corporation Information
6.5.2 Adaltis Srl Description and Business Overview
6.5.3 Adaltis Srl Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Adaltis Srl Molecular Diagnostic Systems Product Portfolio
6.5.5 Adaltis Srl Recent Developments/Updates
6.6 NeuMoDx
6.6.1 NeuMoDx Corporation Information
6.6.2 NeuMoDx Description and Business Overview
6.6.3 NeuMoDx Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2019-2024)
6.6.4 NeuMoDx Molecular Diagnostic Systems Product Portfolio
6.6.5 NeuMoDx Recent Developments/Updates
6.7 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Molecular Diagnostic Systems Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 Hologic
6.8.1 Hologic Corporation Information
6.8.2 Hologic Description and Business Overview
6.8.3 Hologic Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hologic Molecular Diagnostic Systems Product Portfolio
6.8.5 Hologic Recent Developments/Updates
6.9 Mobidiag
6.9.1 Mobidiag Corporation Information
6.9.2 Mobidiag Description and Business Overview
6.9.3 Mobidiag Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mobidiag Molecular Diagnostic Systems Product Portfolio
6.9.5 Mobidiag Recent Developments/Updates
6.10 microLIQUID
6.10.1 microLIQUID Corporation Information
6.10.2 microLIQUID Description and Business Overview
6.10.3 microLIQUID Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2019-2024)
6.10.4 microLIQUID Molecular Diagnostic Systems Product Portfolio
6.10.5 microLIQUID Recent Developments/Updates
6.11 Bruker
6.11.1 Bruker Corporation Information
6.11.2 Bruker Molecular Diagnostic Systems Description and Business Overview
6.11.3 Bruker Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Bruker Molecular Diagnostic Systems Product Portfolio
6.11.5 Bruker Recent Developments/Updates
6.12 Mesa Biotech
6.12.1 Mesa Biotech Corporation Information
6.12.2 Mesa Biotech Molecular Diagnostic Systems Description and Business Overview
6.12.3 Mesa Biotech Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Mesa Biotech Molecular Diagnostic Systems Product Portfolio
6.12.5 Mesa Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Molecular Diagnostic Systems Industry Chain Analysis
7.2 Molecular Diagnostic Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Molecular Diagnostic Systems Production Mode & Process
7.4 Molecular Diagnostic Systems Sales and Marketing
7.4.1 Molecular Diagnostic Systems Sales Channels
7.4.2 Molecular Diagnostic Systems Distributors
7.5 Molecular Diagnostic Systems Customers
8 Molecular Diagnostic Systems Market Dynamics
8.1 Molecular Diagnostic Systems Industry Trends
8.2 Molecular Diagnostic Systems Market Drivers
8.3 Molecular Diagnostic Systems Market Challenges
8.4 Molecular Diagnostic Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Molecular Diagnostic Systems Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Molecular Diagnostic Systems Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Molecular Diagnostic Systems Market Competitive Situation by Manufacturers in 2023
Table 4. Global Molecular Diagnostic Systems Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Molecular Diagnostic Systems Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Molecular Diagnostic Systems Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Molecular Diagnostic Systems Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Molecular Diagnostic Systems Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Molecular Diagnostic Systems, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Molecular Diagnostic Systems, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Molecular Diagnostic Systems, Product Type & Application
Table 12. Global Key Manufacturers of Molecular Diagnostic Systems, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Molecular Diagnostic Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostic Systems as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Molecular Diagnostic Systems Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Molecular Diagnostic Systems Sales by Region (2019-2024) & (K Units)
Table 18. Global Molecular Diagnostic Systems Sales Market Share by Region (2019-2024)
Table 19. Global Molecular Diagnostic Systems Sales by Region (2025-2030) & (K Units)
Table 20. Global Molecular Diagnostic Systems Sales Market Share by Region (2025-2030)
Table 21. Global Molecular Diagnostic Systems Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Molecular Diagnostic Systems Revenue Market Share by Region (2019-2024)
Table 23. Global Molecular Diagnostic Systems Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Molecular Diagnostic Systems Revenue Market Share by Region (2025-2030)
Table 25. North America Molecular Diagnostic Systems Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Molecular Diagnostic Systems Sales by Country (2019-2024) & (K Units)
Table 27. North America Molecular Diagnostic Systems Sales by Country (2025-2030) & (K Units)
Table 28. North America Molecular Diagnostic Systems Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Molecular Diagnostic Systems Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Molecular Diagnostic Systems Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Molecular Diagnostic Systems Sales by Country (2019-2024) & (K Units)
Table 32. Europe Molecular Diagnostic Systems Sales by Country (2025-2030) & (K Units)
Table 33. Europe Molecular Diagnostic Systems Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Molecular Diagnostic Systems Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Molecular Diagnostic Systems Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Molecular Diagnostic Systems Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Molecular Diagnostic Systems Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Molecular Diagnostic Systems Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Molecular Diagnostic Systems Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Molecular Diagnostic Systems Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Molecular Diagnostic Systems Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Molecular Diagnostic Systems Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Molecular Diagnostic Systems Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Molecular Diagnostic Systems Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Molecular Diagnostic Systems Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Molecular Diagnostic Systems Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Molecular Diagnostic Systems Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Molecular Diagnostic Systems Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Molecular Diagnostic Systems Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Molecular Diagnostic Systems Sales (K Units) by Type (2019-2024)
Table 51. Global Molecular Diagnostic Systems Sales (K Units) by Type (2025-2030)
Table 52. Global Molecular Diagnostic Systems Sales Market Share by Type (2019-2024)
Table 53. Global Molecular Diagnostic Systems Sales Market Share by Type (2025-2030)
Table 54. Global Molecular Diagnostic Systems Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Molecular Diagnostic Systems Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Molecular Diagnostic Systems Revenue Market Share by Type (2019-2024)
Table 57. Global Molecular Diagnostic Systems Revenue Market Share by Type (2025-2030)
Table 58. Global Molecular Diagnostic Systems Price (USD/Unit) by Type (2019-2024)
Table 59. Global Molecular Diagnostic Systems Price (USD/Unit) by Type (2025-2030)
Table 60. Global Molecular Diagnostic Systems Sales (K Units) by Application (2019-2024)
Table 61. Global Molecular Diagnostic Systems Sales (K Units) by Application (2025-2030)
Table 62. Global Molecular Diagnostic Systems Sales Market Share by Application (2019-2024)
Table 63. Global Molecular Diagnostic Systems Sales Market Share by Application (2025-2030)
Table 64. Global Molecular Diagnostic Systems Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Molecular Diagnostic Systems Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Molecular Diagnostic Systems Revenue Market Share by Application (2019-2024)
Table 67. Global Molecular Diagnostic Systems Revenue Market Share by Application (2025-2030)
Table 68. Global Molecular Diagnostic Systems Price (USD/Unit) by Application (2019-2024)
Table 69. Global Molecular Diagnostic Systems Price (USD/Unit) by Application (2025-2030)
Table 70. Siemens Corporation Information
Table 71. Siemens Description and Business Overview
Table 72. Siemens Molecular Diagnostic Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Siemens Molecular Diagnostic Systems Product
Table 74. Siemens Recent Developments/Updates
Table 75. Roche Corporation Information
Table 76. Roche Description and Business Overview
Table 77. Roche Molecular Diagnostic Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Roche Molecular Diagnostic Systems Product
Table 79. Roche Recent Developments/Updates
Table 80. Cepheid Corporation Information
Table 81. Cepheid Description and Business Overview
Table 82. Cepheid Molecular Diagnostic Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Cepheid Molecular Diagnostic Systems Product
Table 84. Cepheid Recent Developments/Updates
Table 85. BD Corporation Information
Table 86. BD Description and Business Overview
Table 87. BD Molecular Diagnostic Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. BD Molecular Diagnostic Systems Product
Table 89. BD Recent Developments/Updates
Table 90. Adaltis Srl Corporation Information
Table 91. Adaltis Srl Description and Business Overview
Table 92. Adaltis Srl Molecular Diagnostic Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Adaltis Srl Molecular Diagnostic Systems Product
Table 94. Adaltis Srl Recent Developments/Updates
Table 95. NeuMoDx Corporation Information
Table 96. NeuMoDx Description and Business Overview
Table 97. NeuMoDx Molecular Diagnostic Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. NeuMoDx Molecular Diagnostic Systems Product
Table 99. NeuMoDx Recent Developments/Updates
Table 100. Abbott Corporation Information
Table 101. Abbott Description and Business Overview
Table 102. Abbott Molecular Diagnostic Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Abbott Molecular Diagnostic Systems Product
Table 104. Abbott Recent Developments/Updates
Table 105. Hologic Corporation Information
Table 106. Hologic Description and Business Overview
Table 107. Hologic Molecular Diagnostic Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Hologic Molecular Diagnostic Systems Product
Table 109. Hologic Recent Developments/Updates
Table 110. Mobidiag Corporation Information
Table 111. Mobidiag Description and Business Overview
Table 112. Mobidiag Molecular Diagnostic Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Mobidiag Molecular Diagnostic Systems Product
Table 114. Mobidiag Recent Developments/Updates
Table 115. microLIQUID Corporation Information
Table 116. microLIQUID Description and Business Overview
Table 117. microLIQUID Molecular Diagnostic Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. microLIQUID Molecular Diagnostic Systems Product
Table 119. microLIQUID Recent Developments/Updates
Table 120. Bruker Corporation Information
Table 121. Bruker Description and Business Overview
Table 122. Bruker Molecular Diagnostic Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Bruker Molecular Diagnostic Systems Product
Table 124. Bruker Recent Developments/Updates
Table 125. Mesa Biotech Corporation Information
Table 126. Mesa Biotech Description and Business Overview
Table 127. Mesa Biotech Molecular Diagnostic Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Mesa Biotech Molecular Diagnostic Systems Product
Table 129. Mesa Biotech Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Molecular Diagnostic Systems Distributors List
Table 133. Molecular Diagnostic Systems Customers List
Table 134. Molecular Diagnostic Systems Market Trends
Table 135. Molecular Diagnostic Systems Market Drivers
Table 136. Molecular Diagnostic Systems Market Challenges
Table 137. Molecular Diagnostic Systems Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Molecular Diagnostic Systems
Figure 2. Global Molecular Diagnostic Systems Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Molecular Diagnostic Systems Market Share by Type in 2023 & 2030
Figure 4. Stationary Product Picture
Figure 5. Handheld Product Picture
Figure 6. Global Molecular Diagnostic Systems Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Molecular Diagnostic Systems Market Share by Application in 2023 & 2030
Figure 8. Infectious Disease
Figure 9. Cancer
Figure 10. Others
Figure 11. Global Molecular Diagnostic Systems Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Molecular Diagnostic Systems Market Size (2019-2030) & (US$ Million)
Figure 13. Global Molecular Diagnostic Systems Sales (2019-2030) & (K Units)
Figure 14. Global Molecular Diagnostic Systems Average Price (USD/Unit) & (2019-2030)
Figure 15. Molecular Diagnostic Systems Report Years Considered
Figure 16. Molecular Diagnostic Systems Sales Share by Manufacturers in 2023
Figure 17. Global Molecular Diagnostic Systems Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Molecular Diagnostic Systems Players: Market Share by Revenue in 2023
Figure 19. Molecular Diagnostic Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Molecular Diagnostic Systems Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Molecular Diagnostic Systems Sales Market Share by Country (2019-2030)
Figure 22. North America Molecular Diagnostic Systems Revenue Market Share by Country (2019-2030)
Figure 23. United States Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Molecular Diagnostic Systems Sales Market Share by Country (2019-2030)
Figure 26. Europe Molecular Diagnostic Systems Revenue Market Share by Country (2019-2030)
Figure 27. Germany Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Molecular Diagnostic Systems Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Molecular Diagnostic Systems Revenue Market Share by Region (2019-2030)
Figure 34. China Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Molecular Diagnostic Systems Sales Market Share by Country (2019-2030)
Figure 44. Latin America Molecular Diagnostic Systems Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Molecular Diagnostic Systems Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Molecular Diagnostic Systems Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Molecular Diagnostic Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Molecular Diagnostic Systems by Type (2019-2030)
Figure 54. Global Revenue Market Share of Molecular Diagnostic Systems by Type (2019-2030)
Figure 55. Global Molecular Diagnostic Systems Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Molecular Diagnostic Systems by Application (2019-2030)
Figure 57. Global Revenue Market Share of Molecular Diagnostic Systems by Application (2019-2030)
Figure 58. Global Molecular Diagnostic Systems Price (USD/Unit) by Application (2019-2030)
Figure 59. Molecular Diagnostic Systems Value Chain
Figure 60. Molecular Diagnostic Systems Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
